Borrelia burgdorferi; HME (Human Monocytotropic Ehrlichiosis); Human Granulocytic Anaplasmosis (HGA)
Back to Test Catalogue
Tick-Borne Diseases Panel with Reflex Lyme Disease Immunoblot, Serum (Temporarily Unavailable)
Test ID: TICKBD S
Test
Aliases/Synonyms
Method
EHRC, ANAP, BABG: Immunofluorescence Assay (IFA); LYME: Enzyme-Linked Immunosorbent Assay (ELISA)
Method Description
If Lyme disease screen is positive or equivocal, then Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
Refer to Method Description linked document for details.
Report Includes
Ehrlichia Chaffeensis (HME) Ab, IgG; Anaplasma phagocytophilum Ab, IgG; Babesia microti AB, IgG; Lyme Disease Serology
Specimens
Serum
Clinical Utility
Evaluation of the most common tick-borne diseases found in the United States, including Lyme disease, human monocytic and granulocytic ehrlichiosis, and babesiosis.
Evaluation of patients with a history of, or suspected, tick exposure who are presenting with fever, myalgia, headache, nausea, and other nonspecific symptoms.
Seroepidemiological surveys of the prevalence of the infection in certain populations.
If Lyme disease screen is positive or equivocal, then Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
Test Location
Mayo Clinical Labs, Minnesota USA
Test Version
21-Dec-2023
Specimen
Specimens
Serum
Collection Containers
Preferred
Serum (gel)
Acceptable
Serum (red top)
Sample Volume
1.0 mL
Minimum Volume
0.8 mL
Stability
| Ambient | Not acceptable |
|---|---|
| Refrigerated | 10 days |
| Frozen | 14 days |
Rejection Criteria
| Hemolysis | Gross |
|---|---|
| Lipemia | Gross |
| Other | Grossly icteric; heat inactivated specimen |
Test Version
21-Dec-2023
Performance / Interpretation
Method
EHRC, ANAP, BABG: Immunofluorescence Assay (IFA); LYME: Enzyme-Linked Immunosorbent Assay (ELISA)
Method Description
If Lyme disease screen is positive or equivocal, then Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
Refer to Method Description linked document for details.
Turnaround Time
9 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Ehrlichia Chaffeensis (HME) Antibodies IgG | Titer |
|
||
| Anaplasma phagocytophilum Antibodies IgG | Titer |
|
||
| Babesia microti Antibodies IgG | Titer |
|
||
| Lyme Disease Serology |
|
|||
|
If Lyme disease screen is positive or equivocal, then Lyme disease antibody confirmation (by Western blot) will be performed at an additional charge.
|
||||
Test Location
Mayo Clinical Labs, Minnesota USA
Test Version
21-Dec-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| TICKBD S | 63339Ehrlichia Chaffeensis (HME) Ab, IgG | titer |
| 63340Anaplasma phagocytophilum Ab, IgG, S | titer | |
| 63341Babesia microti IgG Ab | titer | |
| 38596Lyme Disease Serology, S | None |
Test Version
21-Dec-2023